TMCnet News
North American HLA Typing Transplant Diagnostics Services Market 2018-2025 - ResearchAndMarkets.comThe "North America HLA Typing Transplant Diagnostics Services Market - Industry Trends Forecast to 2025" report has been added to ResearchAndMarkets.com's offering. North America HLA typing transplant diagnostics services market is expected to reach USD 474.83 million by 2025, from USD 242.82 million in 2017 growing at a CAGR of 8.8% in the forecast period 2018 to 2025. The report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025. The major factors driving the growth of this market are technological advancements in HLA typing, increasing number of solid organ and stem cell transplantation procedures, risen research grants, funds, and public-private investments are boosting the growth of the North America HLA typing transplant diagnostics services market. p> In 2018, polymerase chain reaction (PCR (News - Alert)) segment is expected to dominate the market with 52% market share and is expected to reach USD 242.58 million by 2025, with a CAGR of 8.6% in the forecast period 2018 to 2025. However, Next-Generation Sequencing (NGS) is expected to grow at the highest CAGR of 9.1% in the forecast period, and is expected to reach USD 232.25 million in 2025 from USD 116.16 million in 2017.In 2018, PCR-SSP (Sequence-Specific Primer) segment is expected to dominate the market with 43.3% market share and is expected to reach USD 199.66 million by 2025, with the CAGR of 8.4% in the forecast period 2018 to 2025. PCR-SBT (Sequencing Based Typing) segment is expected to grow at the highest CAGR of 9.4% in the forecast period, and is expected to reach USD 94.48 million in 2025 from USD 46.32 million in 2017. Key Players Profiled
For more information about this report visit https://www.researchandmarkets.com/research/md9jx6/north_american?w=4 View source version on businesswire.com: https://www.businesswire.com/news/home/20180416006562/en/ |
